Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
RO7297089
i
Other names:
RO7297089, AFM26, RG6296
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Affimed, Roche
Drug class:
BCMA inhibitor, CD16A agonist
Related drugs:
‹
elranatamab-bcmm (8)
JNJ-5322 (3)
teclistamab-cqyv (2)
CC-93269 (2)
CTX-8573 (1)
AMG 701 (1)
MK-4002 (1)
ABBV-383 IV (0)
CDR101 (0)
F182112 (0)
FT576 (0)
ISB 2001 (0)
MBS314 (0)
SAR445514 (0)
SCR-8572 (0)
TQB2934 (0)
WVT078 (0)
REGN5458 (0)
AMG 420 (0)
REGN5459 (0)
AFM24 (3)
AFM13 (3)
AFM13/AB-101 (1)
AFM28 (0)
AFVT-2101 (0)
elranatamab-bcmm (8)
JNJ-5322 (3)
teclistamab-cqyv (2)
CC-93269 (2)
CTX-8573 (1)
AMG 701 (1)
MK-4002 (1)
ABBV-383 IV (0)
CDR101 (0)
F182112 (0)
FT576 (0)
ISB 2001 (0)
MBS314 (0)
SAR445514 (0)
SCR-8572 (0)
TQB2934 (0)
WVT078 (0)
REGN5458 (0)
AMG 420 (0)
REGN5459 (0)
AFM24 (3)
AFM13 (3)
AFM13/AB-101 (1)
AFM28 (0)
AFVT-2101 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login